← Back to Clinical Trials
Recruiting NCT06747689

NCT06747689 Association Between Sleep Quality and Self-Care in Heart Failure Patients

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06747689
Status Recruiting
Phase
Sponsor Dokuz Eylul University
Condition Heart Failure
Study Type OBSERVATIONAL
Enrollment 207 participants
Start Date 2024-12-20
Primary Completion 2025-06-20

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 207 participants in total. It began in 2024-12-20 with a primary completion date of 2025-06-20.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The research will be conducted as a prospective and relational study to longitudinally investigate the effect of sleep quality on self-care in patients with heart failure (HF) and to evaluate the relationship between self-care, sleep quality, and cognitive functions. The sample size was calculated using the multiple linear regression model with the G\*Power Version 3.1 program. Based on a medium effect size of 0.15, an alpha of 0.05, a power of 0.95, and 18 predictors, the sample size was determined to be 188. Considering a potential dropout rate of 10%, it was decided to complete the study with a minimum of 207 participants. Data will be collected from patients who apply to the Dokuz Eylül University Cardiology Outpatient Clinic and meet the inclusion criteria. After signing the informed consent form, participants will be followed up at baseline, the 1st month, the 3rd month, and the 6th month by telephone. The Statistical Package for Social Sciences (SPSS) 24.0 will be used to analyze the numerical data of the research. Descriptive statistics, including number, percentage, mean, and standard deviation, as well as inferential statistics such as the χ2 test, t-test for independent groups, and multiple linear regression, will be employed in the data analysis.

Eligibility Criteria

The study will include patients who: * Are diagnosed with heart failure according to international guidelines, * Are aged 18 years or older, * Can communicate via phone, and * Are willing to participate in the study. Exclusion Criteria: The study will exclude patients who: * Have been hospitalized within one month prior to inclusion, * Have experienced major psychological trauma or stress in the last three months, * Have serious comorbidities or malignant cancers, * Have advanced hearing impairment, * Are using prescription drugs for insomnia or psychiatric conditions, * Work night shifts, or * Reside in nursing homes.

Contact & Investigator

Central Contact

Arzu AKBABA

✉ arzu.akbaba@deu.edu.tr

📞 05373925654

Frequently Asked Questions

Who can join the NCT06747689 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Heart Failure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06747689 currently recruiting?

Yes, NCT06747689 is actively recruiting participants. Contact the research team at arzu.akbaba@deu.edu.tr for enrollment information.

Where is the NCT06747689 trial being conducted?

This trial is being conducted at Izmir, Turkey (Türkiye).

Who is sponsoring the NCT06747689 clinical trial?

NCT06747689 is sponsored by Dokuz Eylul University. The trial plans to enroll 207 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology